Schedule in Cf-252 neutron brachytherapy: complications after delayed implant therapy for cervical cancer in a phase II trial.

National Cancer Institute Conference on Investigational Strategies for Detection and Intervention in Early Ovarian Cancer.

A morphology index based on sonographic findings in ovarian cancer.

Ovarian cancer screening in asymptomatic postmenopausal women.

Images of estrogen-receptor-positive breast tumors produced by estradiol labeled with iodine I 123 at 16 alpha.

Localisation of the breast-ovarian cancer susceptibility gene (BRCA1) on 17q12-21 to an interval of < or = 1 cM.

A feasibility study of 252Cf neutron brachytherapy, cisplatin + 5-FU chemo-adjuvant and accelerated hyperfractionated radiotherapy for advanced cervical cancer.

A feasibility study of 252Cf neutron brachytherapy, cisplatin + 5-FU chemo-adjuvant and accelerated hyperfractionated radiotherapy for advanced cervical cancer.

[Anonymous].  1994.  A feasibility study of 252Cf neutron brachytherapy, cisplatin + 5-FU chemo-adjuvant and accelerated hyperfractionated radiotherapy for advanced cervical cancer.. International journal of radiation oncology, biology, physics. 29(3):529-34.

Hereditary ovarian carcinoma.

Therapeutic implications of lymph nodal spread in lateral T1 and T2 squamous cell carcinoma of the vulva.

The prognostic and therapeutic implications of cytologic atypia in patients with endometrial hyperplasia.